The Efficacy of Vagus Nerve Stimulation in Intractable Epilepsy Associated With Nonketotic Hyperglycinemia in Two Children

Abstract

Nonketotic hyperglycinemia is an inborn error of glycine metabolism and these patients frequently suffer from intractable epilepsy despite treatment with sodium benzoate, dextromethophan, and multiple anticonvulsants. We encountered 2 infants with nonketotic hyperglycinemia whose intractable generalized convulsive seizures were difficult to control with sodium benzoate, dextromethophan, and multiple anticonvulsants. However, after the addition of vagus nerve stimulation, their intractable generalized seizures were >75% reduced in frequency, the numbers of multiple anticonvulsants were reduced, and the quality of life significantly improved. The efficacy in seizure reduction persists for at least 3 years in both children.

Keywords

vagus nerve stimulation intractable epilepsy nonketotic hyperglycinemia

Get full access to this article

View all access options for this article.

References

A randomized, controlled trial of chronic vagus nerve stimulation for the treatment of intractable seizures. The Vagus Nerve Stimulation Study Group. Neurology. 1995;45(2):224-230.

Handforth A. , DeGiorgio CM , Schachter S. , et al. Vagus nerve stimulation therapy from partial-onset seizures: a randomized active-control active-control trial. Neurology. 1998;51(1):48-55.

Hamosh A. , Johnston MV Nonketotic hyperglycinemia. In: Scriver CR , Beaudet AL , Sly WS , Valle D , eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill ; 2001:2065-2078.

Sener RN Nonketotic hyperglycinemia: diffusion magnetic resonance imaging findings . J Comput Assist Tomogr. 2003; 27(4):538-540.

Tsao CY , Wenger GD , Bartholomew DW Cri du Chat syndrome and complex karyotype in a patient with infantile spasms, hypsarrhythmia, nonketotic hyperglycinemia, and heterotopia. Am J Med Genet. 2005;134A(2):198-201.

Helmers SL , Wheless JW , Frost M. , et al. Vagus nerve stimulation therapy in pediatric patients with refractory epilepsy: retrospective study. J Child Neurol. 2001;16(11):843-848.

Wheless JW , Maggio V. Vagus nerve stimulation therapy in patients younger than 18 years. Neurology. 2002;59(6 suppl 4): S21-S25.

Murphy JV Pediatric VNS study group. Left vagal nerve stimulation in children with medically refractory epilepsy. J Pediatr. 1999;134(5):563-566.

Patwardhan RV , Stong B. , Bebin EM , Mathisen J. , Grabb PA Efficacy of vagal nerve stimulation in children with medically refractory epilepsy. Neurosurg. 2000;47(6):1353-1358.

10.

Hosain S. , Nikalov B. , Harden C. , Li M. , Fraser R. , Labar D. Vagus nerve stimulation treatment for Lennox-Gastaut syndrome. J Child Neurol. 2000;15(8):509-512.

11.

Smith B. , Shatz R. , Elisevich K. , Bespalova IN , Burmeister M. Effects of vagus nerve stimulation on progressive myoclonus epilepsy of Unverricht-Lundborg type. Epilepsy. 2000;41(8): 1046-1048.

12.

Frost M. , Gates J. , Helmers SL , et al. Vagus nerve stimulation in children with refractory seizures associated with Lennox-Gastaut syndrome. Epilepsia. 2001;42(9):1148-1152.

13.

Aldenkamp AP , Van de Veerdonk SH , Majoie HJ , et al. Effects of 6 months of treatment with vagus nerve stimulation on behavior in children with Lennox-Gastaut syndrome in an open clinical and nonrandomized study. Epilepsy Behav . 2001;2(4): 343-350.

14.

Morris GL III , Mueller WM Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05. Neurology. 1999;53(8):1731-1735.

15.

DeGiorgio CM , Schachter SC , Handforth A. , et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia. 2000;41(9):1195-1200.